It is estimated that patients receiving critical care in the United States consume at least 20% of total hospital budgeted expenses, 8% of total health-care costs, and nearly 1% of gross domestic product." 2 Of this group, those requiring mechanical ventilation are among the most resource intensive, particularly when ventilator support is prolonged. 3'4 Numerous reports pertaining to the outcome of mechanically ventilated patients have appeared in the scientific literature Key words: age; mechanical ventilation; mortality prediction; outcome examining outcome for elderly patients receiving mechanical ventilatory assistance are representative of this problem. Some authors conclude that age has no impact on the outcome of mechanical ventilation,5'6 while others have noted a significant impact of age,7'10 especially in patients requiring prolonged ventilatory support.Y~0 In all these investigations, the population sizes are less than 100, elderly is variably defined from age 609 to 855 years, and diagnoses and lengths of ventilator duration are quite different.
We investigated the impact of age on outcome of patients requiring mechanical ventilation in New York State. By using a large, comprehensive, statewide database, we expect to determine more conclusively the impact that both age and ICU duration have on outcome from mechanical ventilation.
Limitations in using a data set 
Analysis
The data were received from the Department of Health in the form of frequency distributions. Disposition was obtained for each age. Data were analyzed using two different methods to ascertain the impact of age and ICU duration on outcome. First, multiple regression models were estimated in which the mortality rate at each age above 17 years was regressed on age. Linear, quadratic, and cubic models were estimated to determine if the relationship between mortality rate and age is linear or nonlinear. The cubic model, for example, took the following form:
MR=03o+01AGE+02AGE2+0B3AGE3+E
where MR=Age-specific mortality rate, AGE=patient age in years, do, B1, 02, 03=regression coefficients, and E=random error term.
In addition to the regression analysis, the data were aggregated into ten different age groupings in which the impact of age on outcome could be viewed easily in a table. An analysis of variance test was performed. The null hypothesis (Ho) was the assumption of no difference in outcome across the ten age groups; the alternative hypothesis (Ha) indicates that the outcome is different for at least one of the age groupings:
The F statistic (F*) can be written as follows: F*i=MSTR/MSE=SSTR/(r-l)/SSE/(n-r) where MSTR=treatment mean square, MSE=error mean square, SSTR=treatment sum of square, SSE=error sum of square, r=number of treatments, and n=sample size.
The Tables 5 and 6 summarize the data on duration of ICU and hospital survival that are taken from the 15,527 patients whose record were complete in the UBF data set. The F statistics reveal that both mortality rate and discharge to home rates were significantly affected by duration (p<0.01). As seen, this effect is most pronounced after 2 weeks of ICU stay. Approximately 40% of the mechanically ventilated patient population were in the ICU for less than 3 days; slightly more than one third were in ICU more than 1 week and nearly one sixth were in the ICU more than 2 weeks (reminder, this is ICU duration, not ventilator duration). Table 7 ). Given that patients requiring short-term ventilation are not easily identified using the ventilator procedure codes, it is not surprising that we are observing such high mortality rates (50% overall, ranging from 22% at age 18 years to 75% in the 90+ year age group, and varying from 36 to 61% overall as a function of ICU duration tant, however, are the initial insights into a large data set for studying mechanical ventilation. Our health-care economy is undergoing enormous scrutiny that will undoubtedly result in implicit and explicit policies to help govern the application of resources. Those caring for the mechanically ventilated need better information regarding the scope, outcomes, and costs in these patients. There are several advantages to accessing statewide databases. First, they are in existence. Second, the data acquisition is very inexpensive. Third, they better represent a large segment of the whole population, and are thus at a reduced risk for triage biases found in small studies. There are also several disadvantages. It is difficult to quality control the data handling process. Specifically, because patient identification is deniable, it is extremely difficult to validate the accuracy of data entered into the database. There are, however, data validation techniques in SPARCS as outlined in references 11 and 12. Other problems include the absence of severity information, and the format of the information may not be particularly relevant for select issues, eg, there is no field in SPARCS for days of mechanical ventilation or reason for mechanical ventilation.
The latter criticisms, though valid, are not without an avenue for recourse. SPARCS has a mechanism for altering the data set. New data elements can be introduced, through a well-defined process, as long as their implementation can be justified. Further, as with any data collection, the quality of the data will be related, in part, to the use people make of it. It is important to realize that others, including policy makers and third-party payers, are accessing these types of information systems. In a changing healthcare economy, it would seem advisable to identify and analyze any data sets of this magnitude, and alter them if necessary, to be more meaningful.
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